AF Flashcards

1
Q

How does AF appear on an ecg?

A

Irregular RR intervals, no distinct p waves, rapid and chaotic atrial activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is paroxysmal AF?

A

Recurrent ≥ 2 episodes that terminate within 7 days (≤ 48h terminated with CV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is persistant AF?

A

Continuous>7 days or AF ≥ 48h in which decision made to perform CV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is long standing AF?

A

Continuous AF of >12 months duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is permanent AF?

A

Joint decision by patient and Clinician to cease further attempts to restore or maintain SR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the main symptoms of AF?

A

Palpitations, shortness of breath, fatigue, dizziness, syncope.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which conditions can be commonly associated with AF?

A
Hypertension
Heart failure
Diabetes
Obesity
Sleep apnoea/ chronic lung disease
Valvular heart disease (MV disease)
Congenital heart disease
Coronary artery disease
Thyroid disease
Chronic kidney disease (CKD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens in atrial ablation?

A

The ablation points are centred in the left upper chamber of the heart, or left atrium. A series of ablation points is used to establish a line of lesions. These lines are supposed to block the trigger points of Atrial Fibrillation and create a barrier to the propagation of the arrhythmia. As stated, the lesions target the entrance of the pulmonary veins, of which usually two right and two left ones are found. The lesion points are applied inside the left atrium a few millimeters from the pulmonary vein insertion in the body of the left atrium. This region is known as pulmonary vein antrum. The end point of the procedure is to electrically isolate the pulmonary veins - pulmonary vein isolation or PVI. (wiki)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Again

A

Electrical isolation of the pulmonary veins
Prevents “triggers” and “drivers” of AF
Creates electrically inexcitable “scar” around the PV’s which blocks PV ectopics from entering the left atrium
2-3 hour procedure under conscious sedation with opiate analgesia
Prior anticoagulation with warfarin (or NOAC)
Percutaneous access via femoral veins
Transseptal puncture to access the left atrium (SVC goes to right atrium first)
~ 70% success rates with need for multiple procedures in 25%
2-3% major complication (stroke, tamponade, PV stenosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the main objectives in the management of AF?

A

Stroke prevention, symptom relief, ventricular rate control, correction of rhythm disturbance, optimum management of concomitant cardiovascular disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the factors of the CHADSVAS score?

A

Congestive heart failure/ left ventricular systolic dysfunction 1
Hypertension 1 (consistently over 140/90)
Age >75 2
Diabetes 1
Stroke/TIA 2 (prior stroke or TIA or thromboembolism)
Vascular disease 1
Age 65-74 1
Sex category (female) 1

(female sex category only counts if there are other risk factors present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does the chadvas score determine?

A

The risk of having a stroke in AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the maximum score in the chadvas score?

A

9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the HASBLED score used for?

A

This is used to assess bleeding risk in AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does HASBLED stand for?

A

Hypertension 1
Abnormal renal or liver function 1 or 2 (dialysis/ transplant/ creat >200, Liver disease = cirrhosis/ bilirubin >x2, AST/ ALT > 3x normal)
Stroke 1 (NOT TIA)
Bleeding 1 (previous major bleed or predisposition to bleeding)
Labile INRs 1
Elderly >65 1
Drugs or alcohol 1 point each

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the maximum hasbled score?

A

9

17
Q

If the cha2ds2vas score is >2, what should be offered?

A

Warfarin or novel anticoagulants, dabigatran, rivaroxaban, apixaban.

(if >1 consider anticoagulation)

Do not use aspirin as anti-coag

18
Q

When should rate and rhythm control be offered first line to AF patients?

A

If the AF has a reversible cause,
who have HF thought to be caused by AF,
who have new onset AF

19
Q

Which drugs are used for rhythm control?

A

Standard beta blocker ( not soltolol), also rate-limiting calcium channel blocker (diltiazem).

20
Q

When should digoxin only be used?

A

In non-paroxysmal AF for sedentary patients or if in heart failure

21
Q

NB:

A

Do not use amiordarone for long term rate control

22
Q

What are the options for rhythm control?

A
Antiarrhythmic drug therapy
Beta-blockers
Flecainide, propafenone (pill in the pocket vs regular) 
Sotalol, dronedarone, amiodarone
Cardioversion
Chemical
Electrical
Catheter ablation
23
Q

When can you use cardioversion?

A

DC cardioversion if AF < 48 hours
If AF > 48 hours, requires a period of therapeutic anticoagulation minimum 3 weeks before and 4 weeks afterwards (warfarin with INR>2 or NOAC)

3 CV 4

24
Q

What percentage of patients who have cardioversion will have a recurrence within 12 months?

A

50%

25
Q

Which drug can you give 4 weeks before cardioversion to help improve success rates?

A

Amiordarone

26
Q

What questions to you want to ask a patient with ?AF?

A
How long do episodes last?
How many a day/week?
Associated chest pain, syncope, dizziness, breathlessness, nausea, exercise worsen it or induce it (walking up stairs etc)?
Caffeine intake
PMH PDH
FH
27
Q

What investigations do you do in any patient with suspected AF?

A

ECG, bloods- FBC u&es, lfts, hba1c, tft, lipids, bnp?, ?echo if suspect HF

28
Q

BNP?

A

Brain natriuretic peptide or B-type natriuretic peptide (BNP) (also ventricular natriuretic peptide or natriuretic peptide B) is a 32-amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells (cardiomyocytes). The release of BNP is modulated by calcium ions. -HF